SafeLuna

Company Overview

Snapshot

Founded in January 2016 by Dr. Ilya Fine and Dov Fine, SafeLuna operates with 1–10 employees. The company received a grant from the Interdisciplinary Center Hertziliya in June 2018.

Business overview

SafeLuna develops remote-sensing technology designed to monitor infants. Its core product tracks a sleeping infant's pulse and heart rate without physical contact, aiming to detect signs of sudden infant death syndrome (SIDS) and alert parents via mobile devices. The company operates within the Health Tech & Life Sciences sector, specifically focusing on digital healthcare, patient remote monitoring, and home care solutions.

Strategic signal

In August 2026, SafeLuna ceased operations, indicating a significant shift in its corporate trajectory. This event signals to investors and innovation teams that the company is no longer an active entity in the remote-sensing technology market for infant monitoring.

Company Intelligence Q&A

What is SafeLuna's primary focus?

SafeLuna focuses on developing remote-sensing technology to monitor sleeping infants' pulse and heart rate, aiming to detect early signs of sudden infant death syndrome (SIDS).

When was SafeLuna founded and by whom?

SafeLuna was founded in January 2016 by Dr. Ilya Fine and Dov Fine.

What was a notable early funding event for SafeLuna?

In June 2018, SafeLuna received a grant from the Interdisciplinary Center Hertziliya.

What is the current operational status of SafeLuna?

SafeLuna ceased to operate in August 2026.

What technology does SafeLuna utilize?

SafeLuna utilizes real-time sensing technology to remotely monitor physiological parameters of infants without physical contact, providing alerts for abnormal heart rates.